Richard D. Dyer

3.6k total citations
58 papers, 3.1k citations indexed

About

Richard D. Dyer is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Richard D. Dyer has authored 58 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 21 papers in Pharmacology and 11 papers in Molecular Biology. Recurrent topics in Richard D. Dyer's work include Inflammatory mediators and NSAID effects (19 papers), Synthesis and Reactions of Organic Compounds (15 papers) and Synthesis and biological activity (14 papers). Richard D. Dyer is often cited by papers focused on Inflammatory mediators and NSAID effects (19 papers), Synthesis and Reactions of Organic Compounds (15 papers) and Synthesis and biological activity (14 papers). Richard D. Dyer collaborates with scholars based in United States, Canada and United Kingdom. Richard D. Dyer's co-authors include Denis J. Schrier, Linda L. Johnson, Donald Hupe, Catherine R. Kostlan, James B. Summers, Paul C. Unangst, David T. Connor, Dee W. Brooks, Michael D. Mullican and Patrick Young and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Biochemistry.

In The Last Decade

Richard D. Dyer

58 papers receiving 2.9k citations

Peers

Richard D. Dyer
Manfred Wießler Germany
Hisao Nakai Japan
Hiroshi Fujii Japan
Carlo Irace Italy
Takeshi Kinoshita Japan
Hirofumi Nakano Japan
Bhaskar C. Das United States
Thomas Robert France
Jeffrey A. Dodge United States
Song Ja Kim South Korea
Manfred Wießler Germany
Richard D. Dyer
Citations per year, relative to Richard D. Dyer Richard D. Dyer (= 1×) peers Manfred Wießler

Countries citing papers authored by Richard D. Dyer

Since Specialization
Citations

This map shows the geographic impact of Richard D. Dyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Dyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Dyer more than expected).

Fields of papers citing papers by Richard D. Dyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Dyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Dyer. The network helps show where Richard D. Dyer may publish in the future.

Co-authorship network of co-authors of Richard D. Dyer

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Dyer. A scholar is included among the top collaborators of Richard D. Dyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Dyer. Richard D. Dyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lescord, Gretchen L., Thomas A. Johnston, Wendel Keller, et al.. (2019). Arsenic, chromium, and other elements of concern in fish from remote boreal lakes and rivers: Drivers of variation and implications for subsistence consumption. Environmental Pollution. 259. 113878–113878. 16 indexed citations
2.
Li, Jie Jack, Adam R. Johnson, Amy Bunker, et al.. (2008). Quinazolinones and Pyrido[3,4- d ]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis. Journal of Medicinal Chemistry. 51(4). 835–841. 74 indexed citations
3.
Johnson, Adam R., A.G. Pavlovsky, Daniel F. Ortwine, et al.. (2007). Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects. Journal of Biological Chemistry. 282(38). 27781–27791. 176 indexed citations
4.
Johnson, Linda L., Richard D. Dyer, & Donald Hupe. (1998). Matrix metalloproteinases. Current Opinion in Chemical Biology. 2(4). 466–471. 237 indexed citations
5.
Djurić, Stevan W., Richard D. Dyer, & Keith B. Glaser. (1997). Therapeutic Regulation of Allergic and Inflammatory Diseases, Fifth Annual Midwest Meeting, Chicago, IL, USA, 11 April 1997. Inflammation Research. 46(12). 482–485. 1 indexed citations
6.
Cornicelli, Joseph A., Kathryn Welch, Thomas Bocan, et al.. (1997). Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant properties. British Journal of Pharmacology. 120(7). 1199–1206. 150 indexed citations
7.
Emmerling, Mark R., et al.. (1996). The Role of Arachidonic Acid in the Secretion of the Amyloid Precursor Protein (APP)a. Annals of the New York Academy of Sciences. 777(1). 310–315. 18 indexed citations
8.
Johnson, Jennifer L., Jeffrey Wimsatt, Scott D. Buckel, Richard D. Dyer, & Krishna Rao Maddipati. (1995). Purification and Characterization of Prostaglandin H Synthase-2 from Sheep Placental Cotyledons. Archives of Biochemistry and Biophysics. 324(1). 26–34. 107 indexed citations
9.
Kramer, James B., Thomas Capiris, Jagadish C. Sircar, et al.. (1995). Hydroxylamine analogs of 2,6 di-t-butylphenols: Dual inhibitors of cyclooxygenase and 5-lipoxygenase or selective 5-lipoxygenase inhibitors. Bioorganic & Medicinal Chemistry. 3(4). 403–410. 10 indexed citations
10.
11.
Unangst, Paul C., David T. Connor, Wiaczeslaw A. Cetenko, et al.. (1994). Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity. Journal of Medicinal Chemistry. 37(2). 322–328. 138 indexed citations
12.
Mullican, Michael D., et al.. (1993). Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally active, nonulcerogenic antiinflammatory agents. Journal of Medicinal Chemistry. 36(8). 1090–1099. 337 indexed citations
13.
Boschelli, Diane H., David T. Connor, Dirk A. Bornemeier, et al.. (1993). 1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities. Journal of Medicinal Chemistry. 36(13). 1802–1810. 173 indexed citations
14.
Unangst, Paul C., David T. Connor, Wiaczeslaw A. Cetenko, et al.. (1993). Oxazole, thiazole, and imidazole derivatives of 2,6-di-tert-butylphenol as dual 5-lipoxygenase and cyclooxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 3(8). 1729–1734. 22 indexed citations
15.
Brooks, Dee W., Steven P. Schmidt, Richard D. Dyer, Patrick Young, & George W. Carter. (1992). Structural analysis of 2-aryl-1,3-dione compounds as inhibitors of 5-lipoxygenase. Bioorganic & Medicinal Chemistry Letters. 2(10). 1309–1314. 2 indexed citations
16.
Unangst, Paul C., et al.. (1992). Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors. Journal of Medicinal Chemistry. 35(20). 3691–3698. 179 indexed citations
17.
Summers, James B., Ki H. Kim, Hormoz Mazdiyasni, et al.. (1990). Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. Journal of Medicinal Chemistry. 33(3). 992–998. 47 indexed citations
18.
Shihabi, Zak K. & Richard D. Dyer. (1988). Protein analysis with bicinchoninic acid.. PubMed. 18(3). 235–9. 39 indexed citations
19.
Summers, James B., Bruce P. Gunn, Hormoz Mazdiyasni, et al.. (1988). Orally active hydroxamic acid inhibitors of leukotriene biosynthesis. Journal of Medicinal Chemistry. 31(1). 3–5. 42 indexed citations
20.
Summers, James B., Bruce P. Gunn, Hormoz Mazdiyasni, et al.. (1987). In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase. Journal of Medicinal Chemistry. 30(11). 2121–2126. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manfred Wießler Breakdown of academic impact, for papers by Hisao Nakai Breakdown of academic impact, for papers by Hiroshi Fujii Breakdown of academic impact, for papers by Carlo Irace Breakdown of academic impact, for papers by Takeshi Kinoshita Breakdown of academic impact, for papers by Hirofumi Nakano Breakdown of academic impact, for papers by Bhaskar C. Das Breakdown of academic impact, for papers by Thomas Robert Breakdown of academic impact, for papers by Jeffrey A. Dodge Breakdown of academic impact, for papers by Song Ja Kim
Rankless by CCL
2026